Bullet Points
- •Heart failure is a very prevalent condition in people older than 65 years and, therefore, it is important to investigate the factors that are involved in the increase of both morbidity and mortality.
- •In the era of vaccination in which we find ourselves, it is important to try continuously to show the protective effects of this medical tool, in this case, not only in patients with chronic heart failure but also in those with acute heart failure.
- •Spending time researching the methods can protect our patients who suffer from heart failure gives us more possibilities for improving their quality of life and their life expectancy.
ABSTRACT
Objective
To investigate the relationship of seasonal flu vaccination with the severity of decompensation
and long-term outcomes of patients with heart failure (HF).
Methods
We analyzed 6147 consecutively enrolled patients with decompensated HF who presented
to 33 Spanish emergency departments (EDs) during January and February of 2018 and
2019, grouped according to seasonal flu vaccination status. The severity of HF decompensation
was assessed by the Multiple Estimation of Risk Based on the Emergency Department
Spanish Score in Patients With Acute Heart Failure (MEESSI-AHF) + MEESSI scale, need
of hospitalization and in-hospital all-cause mortality. The long-term outcomes analyzed
were 90-day postdischarge adverse events and 90-day all-cause death. Associations
between vaccination, HF decompensation severity and long-term outcomes were explored
by unadjusted and adjusted logistic and Cox regressions by using 14 covariables that
could act as potential confounders.
Results
Overall median (IQR) age was 84 (IQR = 77-89) years, and 56% were women. Vaccinated
patients (n = 1139; 19%) were older, had more comorbidities and had worse baseline
status, as assessed by New York Heart Association class and Barthel index, than did
unvaccinated patients (n = 5008; 81%). Infection triggering decompensation was more
common in vaccinated patients (50% vs 41%; P < 0.001). In vaccinated and unvaccinated patients, high or very-high risk decompensation
was seen in 21.9% and 21.1%; hospitalization occurred in 72.5% and 73.7%; in-hospital
mortality was 7.4% and 7.0%; 90-day postdischarge adverse events were 57.4% and 53.2%;
and the 90-day mortality rate was 15.8% and 16.6%, respectively, with no significant
differences between cohorts. After adjusting, vaccinated decompensated patients with
HF had decreased odds for hospitalization (OR = 0.823, 95%CI = 0.709–0.955).
Conclusion
In patients with HF, seasonal flu vaccination is associated with less severe decompensations.
Graphical Abstract

Graphical Abstract
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiac FailureAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- ADHERE Scientific Advisory Committee. Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry.Heart Fail Rev. 2004; 9: 179-185
- Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure.Clin Res Cardiol. 2018; 107: 897-913
- Management of acute decompensated heart failure in Spain: where are we now?.Emergencias. 2022; 34: 81-82
- Thirty-day outcomes in frail older patients discharged home from the emergency department with acute heart failure: effects of high-risk criteria identified by the DEED FRAIL-AHF trial.Emergencias. 2021; 33: 165-173
- ESC Heart Failure Long-Term Registry Investigators. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.Eur J Heart Fail. 2017; 19: 1242-1254
- Trends and complications associated with acute new-onset heart failure: a National Readmissions Database-based cohort study.Heart Fail Rev. 2021; (in press)https://doi.org/10.1007/s10741-021-10152-3
- In-hospital initiation of quadruple medical therapy for heart failure: making the post-discharge vulnerable phase far less vulnerable.Eur J Heart Fail. 2022; 24: 227-229
- Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study.Clin Res Cardiol. 2021; 110: 993-1005
- Influenza Vaccination and outcome in heart failure.Am J Cardiol. 2020; 128: 134-139
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.Lancet. 2018; 391: 1285-1300
- Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: a systematic review and meta-analysis.PLoS Med. 2021; 18e1003550
- Impact of identifying precipitating factors on 30-day mortality in acute heart failure patients.Eur Heart J Acute Cardiovasc Care. 2019; 8: 667-680
- Current Spanish emergency department organization and clinical practices in caring for patients with acute heart failure.Emergencias. 2022; 34: 85-94
- Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality.Eur J Heart Fail. 2018; 20: 295-303
- Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations.Ther Adv Vaccines Immunother. 2019; 72515135519826481
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J. 2021; 42: 3599-3726
- 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation. 2013; 128: 1810-1852
- Sarría-Santamera A. Effects of annual influenza vaccination on mortality in patients with heart failure.Eur J Pub Health. 2016; 26: 890-892
- Safety and the identification of modifiable factors in older patients discharged from the emergency department with acute heart failure.Emergencias. 2021; 33: 161-162
- Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF Trial.JACC Heart Fail. 2016; 4: 152-158
- Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study.Eur Heart J. 2017; 38: 326-333
- Predicting 30-day mortality for patients with acute heart failure in the emergency department: a cohort study.Ann Intern Med. 2017; 167: 698-705
- Acute heart failure in subtropical climates: clinical characteristics, management, and outcomes in the Canary Islands versus continental Spain: the CANAR-ICA study results.Emergencias. 2021; 33: 413-420
- Survival after the onset of congestive heart failure in Framingham heart study subjects.Circulation. 1993; 88: 107-115
- Long-term survival and life expectancy following an acute heart failure hospitalization.Eur J Heart Fail. 2022; 24: 1519-1528
Miró O, Conde-Martel A, Llorens P, Salamanca-Bautista P, Gil V, González-Franco A, et al. The influence of comorbiditeis in long-term prognosis after an acute heart failure decompensation and differences according to ejection fraction: results from the EAHFE and RICA registries. Eur J Intern Med (submitted) in press.
- Principles of confounder selection.Eur J Epidemiol. 2019; 34: 211-219
- The hazards of hazard ratios.Epidemiology. 2010; 21: 13-15
- Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.Eur J Heart Fail. 2017; 19: 201-208
- Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study.Clin Res Cardiol. 2020; 109: 34-45
- . Influenza vaccine in heart failure.Circulation. 2019; 139: 575-586
- The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis.Heart Fail Rev. 2019; 24: 109-114
- Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies.Heart. 2020; 106: 350-357
- The impact of ageing on monocytes and macrophages.Immunol Lett. 2021; 230: 1-10
- Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF Trial.JACC Heart Fail. 2016; 4: 152-158
Article info
Publication history
Published online: January 24, 2023
Accepted:
December 28,
2022
Received in revised form:
December 22,
2022
Received:
June 17,
2022
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.